Cancer Research & Treatment Fund, Inc.

Cancer Research & Treatment Fund, Inc. The official page of Cancer Research & Treatment Fund. Please follow us to receive our latest news. In 2012, CR&T began funding the Richard T. Silver.

The Cancer Research and Treatment Fund (CR&T) is a driving force in cancer research and treatment. Founded in 1968, we are a not-for-profit fund that is committed to the belief that advances in blood cancer research lead to important breakthroughs, and a better understanding of the biology and treatment of all forms of cancer. In 2000, CR&T and the generosity of donors were instrumental in the est

ablishment of the Center for the Study of Leukemia and Myeloproliferative Neoplasms at Weill Cornell Medical College, a leading institution for cancer research. More recently, we have been involved with the breakthrough discoveries of Gleevec and now the JAK2 enzyme cancer marker . Silver Myeloproliferative Neoplasm Center at Weil Cornell Medical College, the successor to the Center for the Study of Leukemia and Myelproliferative Neoplasms at Weill Cornel Medical College. The center was dedicated in a special ceremony on February 18, 2014, and will serve as a translational research and treatment center, engaging in cutting edge discoveries surrounding MPNs. CR&T played a pivotal role in establishing the Silver MPN Center. In addition to contributing a $3.7 million gift, the Center is named after CR&T’s founder, Dr. Richard T. Dr. Andrew Schaefer, former Chairman of the Department of Medicine at Weill Cornell Medical College, has been appointed as the Center’s Director. We have achieved these successes by aggressively pursuing biological, pharmacological and molecular solutions to understand cancer, and to design drugs and diagnostic tools based on new knowledge—providing critical resources for a multidisciplinary approach that offers the greatest promise against all forms of cancer. For more than three decades, CR&T has been a major source of financial support for researchers on the frontlines of clinical cancer research at Weill Medical College of Cornell University, located at New York-Presbyterian Hospital. We have also awarded grants for research at Johns Hopkins University Medical Center, MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center.

05/31/2026

This National Cancer Research Month, we're taking a moment to honor our late founder, Richard T. Silver, M.D. Dr. Silver dedicated his career to cancer research and treatment, pioneering treatment options like interferon use in MPN cancer and refining diagnostic techniques like bone marrow biopsy. He was an esteemed researcher, educator and colleague, a beloved physician, and a true force within the blood cancer and oncology community.

Dr. Silver remained dedicated to cancer research until he passed away, just last month. In his career, he authored hundreds of peer-reviewed papers and contributed to 20 book chapters and countless abstracts. He organized conferences, educated patients, and pushed for international collaboration in oncology. His work saved and continues to save countless lives.

We are honored to continue the fight against cancer in his name. And so we wish you a happy National Cancer Research Month, Dr. Silver. Know that we will keep pushing forward until we find a cure.

Join us at the 15th Annual Richard T Silver International Patient Symposium for individuals with MPNs, their families, f...
05/27/2026

Join us at the 15th Annual Richard T Silver International Patient Symposium for individuals with MPNs, their families, friends, and caregivers! We are thrilled to announce that registration for the 2026 symposium is just $10 for patients and caregivers, thanks to our generous sponsors.

This full-day event will dive into the latest research developments, connect them to treatment practices, and offer patients and their support systems unique opportunities to engage with guest speakers from the most prestigious cancer centers around the world. We’re gathering researchers from Copenhagen to Boston to New York to Texas to North Carolina, representing institutions including M.D. Anderson Cancer Center, Mass General Cancer Center, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, Weill Cornell, Wake Forest University School of Medicine, and New York-Presbyterian.

This year’s agenda includes sessions on longevity with MPN cancer, risk management for young adults with genetic predispositions, cardio and lifestyle, breakout sessions on individual MPNs, a live Q&A, and more! The symposium also offers connection as you spend the day amongst people who know what you and your loved ones are going through.

Wednesday, October 28, 2026
Belfer Research Building, Weill Cornell Medicine
413 E 69th St, New York, NY 10021

Register here at the link below!

*Financial hardship should never prevent patient education. If the registration fee is prohibitive, please reach out to Mike at [email protected] to request easily available financial assistance!

05/19/2026

It’s mental health awareness month.

An estimated 20-33% of patients diagnosed with cancer will experience depression, anxiety, or another serious mental health disruption. It makes sense--cancer threatens and disrupts your life. When it comes to MPN cancer, that disruption is long-term, as MPNs require lifelong management.

It’s OK for you and your loved ones to feel sad, upset, overwhelmed, fearful, anxious, or even angry as you navigate your “new normal.” These feelings are not evidence of a mental health condition. However, ignoring them can lead to an episode of depression.

The good news is that there are many things you can do to avoid that outcome. Most of them are simple, and it's easy to get started.

(1) Acknowledge how you're feeling. Studies show that cancer patients who express their emotions and seek support from people they trust are less likely to experience depression.

(2) Don't self-isolate. Close connections and frequent contact with friends and family can keep depression at bay. Talk to your friend, sibling, partner, doctor, minister, rabbi—anyone who makes you comfortable.

(3) Move as much as possible. Exercise releases endorphins, or natural mood elevators, in the brain. Choosing exercise can also help you feel more in control of your life and body.

Always speak to your doctor and respect your limitations before exercising.

(4) Take an active role in improving your mental health. Remember that you are responsible for how you act on your feelings, and that’s a good thing! Try to embrace a problem-solving approach. Whether that involves exercise, structured social time, meditation, journaling or something else, your participation is the most important part.

(5) Seek out professional help when you need it. Even the most diligent self-care is not infallible. Sometimes, depression happens when you do not expect it. If you find yourself in that situation, you’re not alone, and help is available.

We’ve linked some free mental health resources for cancer patients below.

Take care.

It's National Women's Health Week! Let's talk about an MPN that impacts twice as many women as men: Essential thrombocyt...
05/12/2026

It's National Women's Health Week! Let's talk about an MPN that impacts twice as many women as men: Essential thrombocythemia (ET). ET happens when your bone marrow produces too many platelets, raising the risk of clotting and, in some cases, bleeding. While most patients are diagnosed between 60 and 80 years old, 20% of patients involve people under the age of 40. Learn more ET basics below, and join us at our 15th Annual Richard T. Silver, MD International Patient Symposium on Wednesday October 28, 2026, for the latest MPN research and advances, straight from world-renowned clinicians.

We're proud to support the 21st Annual Prostate Screening and Health Fair at First Presbyterian Church in Jamaica on May...
04/30/2026

We're proud to support the 21st Annual Prostate Screening and Health Fair at First Presbyterian Church in Jamaica on May 2, 2026 from 9 am to 1 pm. One thing is true across diseases: early detection saves lives and educated patients have better health outcomes. This screening and education event is free and open to the public; no health insurance required.

Complimentary breakfast is available at 8 am. Parking will be available at The Coliseum Parking lot, located 88-35 164th Street and Impark Garage at 162/163 Street. Parking tickets can be validated at the Health Fair.

It is with deep sadness that we share that our founder, Dr. Richard T. Silver, passed away peacefully at the age of 97.A...
04/20/2026

It is with deep sadness that we share that our founder, Dr. Richard T. Silver, passed away peacefully at the age of 97.

A temple service will be held on Monday, April 20th at 10:30AM at Temple Emanu-El, 1 East 65th Street (5th Avenue), New York, NY 10065. Temple Emanu-El will be offering a livestream of the funeral service, which will begin at approximately 10:25 AM on Monday. You are warmly invited to join via the link below.
https://emanuelnyc.org/worship/livestream/

Dr. Silver lived an extraordinary life defined by compassion, purpose, and an unwavering commitment to others. A pioneer in the field of medicine—particularly in the fight against blood cancer—his research and clinical work touched countless lives and helped shape the course of care for generations of patients. Beyond his remarkable professional achievements, he was a humanitarian at heart, dedicating himself not only to advancing science but to caring for each individual with dignity, empathy, and hope.

Those who had the privilege of knowing him witnessed a life led with integrity, brilliance, and profound kindness. His legacy will endure not only through his contributions to medicine, but through the many lives he changed, the patients he comforted, the students he mentored, and the inspiration he leaves behind.

We keep his family in our thoughts during this difficult time. We are indescribably grateful for his work in founding CR&T and look forward to continuing his legacy.

Memorial donations can be made at crt.org.

Polycythemia Vera (PV) is the most common type of MPN cancer. As we work with researchers tirelessly seeking a cure, we ...
04/17/2026

Polycythemia Vera (PV) is the most common type of MPN cancer. As we work with researchers tirelessly seeking a cure, we also watch patients manage this slow-moving, long-term disease that requires a marathon of medical care.

PV In Focus events offer those patients much-needed mental health and self-advocacy tools, alongside treatment information and key patient perspectives. Learn more about these free events, below!

Congratulations to CR&T Board Member Kasia McCormick on her appointment to the board of The New York Pops! Kasia was CR&...
04/16/2026

Congratulations to CR&T Board Member Kasia McCormick on her appointment to the board of The New York Pops! Kasia was CR&T's 2025 Richard T. Silver, M.D. Humanitarian Award winner for a reason—her passion for community work is as inspiring as it is impactful. We are so proud of everything she has accomplished! We know she will bring the same drive to the New York Pops.

Clinical trials are key to advancing care for people living with MPNs. At the Silver MPN Center, patients have access to...
03/25/2026

Clinical trials are key to advancing care for people living with MPNs. At the Silver MPN Center, patients have access to innovative trials that help define tomorrow’s therapies. Participation helps science AND patient care.

A gift to CR&T has the potential to truly change the lives of those battling MPN's. No gift is too small to make a chang...
03/24/2026

A gift to CR&T has the potential to truly change the lives of those battling MPN's. No gift is too small to make a change. https://www.crt.org/donate/

Address

500 E 77th Street, Ste 1001
New York, NY
10162

Opening Hours

Monday 9:30am - 5:30pm
Tuesday 9:30am - 5:30pm
Wednesday 9:30am - 5:30pm
Thursday 9:30am - 5:30pm
Friday 9:30am - 5:30pm

Website

Alerts

Be the first to know and let us send you an email when Cancer Research & Treatment Fund, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cancer Research & Treatment Fund, Inc.:

Shortcuts

Share

Category